Overview

Dopaminergic Modulation of Declarative Memory

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The study investigates the effect of dopaminergic stimulation over declarative memory functions in Parkinson's disease (PD) patients. At this aim, 20 PD patients will receive declarative memory tasks in two different conditions: after 12-18 hours of dopaminergic stimulation withdrawal ("off" condition) and after the first daily dose dopaminergic therapy ("on" condition). 20 healthy controls will also administered the two tasks in two conditions with the same inter-session delay as PD patients, but without taking drugs.
Phase:
Phase 4
Details
Lead Sponsor:
I.R.C.C.S. Fondazione Santa Lucia
Treatments:
Dopamine
Dopamine Agents
Dopamine Agonists